Introduction
============

In most countries of the world, breast cancer is the most prevalent cancer.[@b1-bctt-9-051],[@b2-bctt-9-051] Saudi Arabia is no exception: breast cancer is reported to be the most common cancer in Saudi women, particularly among women aged ≥45 years.[@b3-bctt-9-051] The average Saudi woman's age at diagnosis is 49 years.[@b3-bctt-9-051] New cases of breast cancer among Saudi women have increased from 1,430 in 1996[@b3-bctt-9-051],[@b4-bctt-9-051] to 1,542 in 2012.[@b4-bctt-9-051] Later, the kingdom's Ministry of Health reported that 2,741 new breast cancer cases were diagnosed in Saudi Arabia. The Saudi National Cancer Registry reported an increase of breast cancer among Saudi women from 19.1% (based on a 1996 report) to 25.8% (based on a 2012 report), including all newly diagnosed cancer tumors. The incidence rates of breast cancer vary by geographic regions: 32.6 per 100,000 in Eastern, 31.6 per 100,000 in Jouf, and 25.6 per 100,000 in Riyadh.[@b4-bctt-9-051]

There are several treatment options used worldwide for breast cancer. The choices may depend on the type of breast cancer, stage, tumor size, and the patient's demographics and reactions to hormones. In Saudi Arabia, treatment of breast cancer may involve surgery, antibodies, chemotherapy, hormone therapy, and radiation, or there could be a combination of treatments. Patients with breast cancer tend to experience a poor quality of life (QoL) during or after the treatment course.[@b5-bctt-9-051] As the result of a mastectomy, women with breast cancer reported a poor self-image 1 month after surgery and a poor QoL 1 year after the cancer diagnosis.[@b6-bctt-9-051] A study of 86 patients reported that breast cancer may affect a woman's sexual activity.[@b7-bctt-9-051] A study in Australia assessed the impact of breast cancer and surgery on QoL classified by age and marital status. According to the authors, women who were young, single, and lacked education reported worse QoL than older, married, and educated women.[@b8-bctt-9-051] Furthermore, a mastectomy tended to have a negative effect on body image among married women.[@b8-bctt-9-051],[@b9-bctt-9-051] Another study reported that \>70% of young women experienced pain and unhappiness with regard to appearance.[@b10-bctt-9-051] Breast cancer patients commonly experience major psychological symptoms, including depression, anxiety, and stress.[@b11-bctt-9-051]--[@b14-bctt-9-051]

A 2011 study reveals that Arab women with breast cancer, especially those receiving little support and those with a poor body image, experienced powerful psychological distress.[@b15-bctt-9-051] A different study reported that young Arab women experienced more negative emotions regarding their illnesses than older Arab women.[@b16-bctt-9-051] There are several studies that assessed QoL in Arab breast cancer patients in various countries: Egypt,[@b17-bctt-9-051]--[@b19-bctt-9-051] United Arab Emirates,[@b20-bctt-9-051] Kuwait,[@b21-bctt-9-051] Tunisia,[@b22-bctt-9-051] Yemen,[@b23-bctt-9-051] Lebanon,[@b24-bctt-9-051] Bahrain,[@b25-bctt-9-051],[@b26-bctt-9-051] Morocco,[@b27-bctt-9-051] and Jordan.[@b28-bctt-9-051] There is little data on the connection between breast cancer and QoL among Saudi women, where only a single study has assessed the QoL among breast cancer patients in Saudi Arabia.[@b29-bctt-9-051] This study in Riyadh, Saudi Arabia, used the European Organisation for Research and Treatment of Cancer to measure QoL of breast cancer patients who were recruited from different outpatient clinical settings. There appears to be poor overall global QoL,[@b29-bctt-9-051] but this study did not assess the influence of the side effects of treatment and other clinical factors on QoL. Today, however, placing attention on cancer patients is increasingly common worldwide, as it allows researchers to introduce intervention to reduce the psychological effects of the diagnosis or treatment.

Despite this earlier lack of attention, there are several studies in the literature assessing attitude, awareness, and knowledge of breast cancer and its self-examination among Saudi women in various regions.[@b30-bctt-9-051]--[@b37-bctt-9-051] However, not much is known about the influence of the side effects of treatment and other clinical factors on the QoL of Saudi women with breast cancer. Clinicians would benefit from this study by promptly being able to assess the QoL in order to provide proper treatment.

Purpose
=======

The purpose of this study is to efficiently assess the QoL of Saudi women with breast cancer when compared with sociodemographic factors. We hypothesized that breast cancer in Saudi women may negatively affect their QoL, and we also investigated whether QoL depends on any sociodemographic factors.

Methods
=======

A cross-sectional study was conducted in the Oncology Outpatient Clinic at King Abdulaziz Medical City, Riyadh, Ministry of National Guard Health Affairs, where we assessed QoL in a sample of female breast cancer patients. The study received ethical approval from the Institutional Review Board (IRB) at King Abdullah International Medical Research Center, IRB approval \# RSS16/004. A consecutive sample of women with breast cancer who were seen in the Oncology Outpatient Clinic during the study period (August 14--31, 2016) were asked to participate in a one-time survey to assess QoL and psychological symptoms. The participants of the study received a survey with a cover letter explaining the aims of the study and asking whether they wanted to participate. Only patients who agreed to participate in the study were included and asked to complete a survey. We excluded breast cancer patients who had been referred to palliative care. We distributed 170 questionnaires to women with breast cancer who attended the oncology clinic during the study period, and 145 (85.3%) questionnaires were completed and returned. Completion of survey is deemed to be agreement of consent from the 145 participants.

The first section of the survey covers sociodemographic characteristics. We asked women about their age, weight, height, marital status, education level, employment status, monthly income category, physical exercise, and whether they received family support. Furthermore, we collected data about patient clinical and cancer characteristics (eg, comorbidity factors, types of treatment received to treat breast cancer, cancer grade, metastasis, fever, and chronic disease other than cancer).

Study instruments
=================

In this study, we assessed the QoL of breast cancer patients using the Medical Outcome Study Health Survey 36-Item Short Form (SF-36).[@b38-bctt-9-051] The questionnaire was found to be reliable and valid and its Arabic version is publicly available.[@b39-bctt-9-051] The SF-36 is comprised of items addressing eight health concepts: role limitation due to physical health, physical functioning, role limitations due to emotional problems, social functioning, vitality, bodily pain, emotional well-being, and general health perceptions. SF-36 items were scored based on the RAND Health Scoring System.[@b38-bctt-9-051] For example, the total of each mentioned domain ranges from 0=poor to 100=best health. In our population, the SF-36 subscales were reliable and demonstrated good internal consistency: physical functioning (Cronbach's alpha=0.91), role limitations due to physical health (Cronbach's alpha=0.86), role limitations due to emotional problems (Cronbach's alpha=0.87), vitality (Cronbach's alpha=0.74), emotional well-being (Cronbach's alpha=0.80), social functioning (Cronbach's alpha=0.87), pain (Cronbach's alpha=0.88), and general health (Cronbach's alpha=0.69).

Statistical analyses
====================

The data analyses were performed using IBM SPSS Statistics 23 (IBM Corp, Armonk, NY, USA).

Patients' sociodemographics
---------------------------

Descriptive statistics, such as mean and standard deviation (mean±SD), were used to describe the quantitative variables. Frequencies and percentages n (%) were used to describe categorical variables ([Table 1](#t1-bctt-9-051){ref-type="table"}).

Bivariate analyses
------------------

To account for 19 multiple comparisons, the Bonferroni correction of α/n=0.05/19=0.003 was used to compare QoL between the groups ([Tables 1](#t1-bctt-9-051){ref-type="table"} and [2](#t2-bctt-9-051){ref-type="table"}). Specifically, we will compare physical functioning, role limitations due to physical health, role limitations due to emotional problems, vitality, social functioning, bodily pain, general health, physical well-being, social/family well-being, emotional well-being, and functional well-being perceptions across sociodemographic and clinical characteristics.

Multivariate analyses
---------------------

Multiple linear regression models were used to identify predictors of the SF-36 subscales ([Table 3](#t3-bctt-9-051){ref-type="table"}). The regression coefficients will be used to interpret the linear regression findings. In all multivariate analyses, the significance level (*a*) was set at 0.05.

Results
=======

Our analysis included 145 female patients with breast cancer. The sample studied was relatively old. The mean age was 50.3 (±SD=13.5) years with an age range between 21 and 87 years, and 22.1% were elderly women aged ≥60 years. Of the sample studied, 42.1% had a family history of cancer, 74.5% were unemployed, 37.2% were obese, and 25.5% reported having multiple tumors. Other clinical and demographic details are shown in [Table 1](#t1-bctt-9-051){ref-type="table"}. The median number of months after breast cancer diagnosis was 12 with percentiles (q1=6, q3=24). Differences across sociodemographic and clinical data are shown for all eight domains in [Tables 1](#t1-bctt-9-051){ref-type="table"} and [2](#t2-bctt-9-051){ref-type="table"}. Breast cancer patients who were elderly, with high school education or less, had multiple tumors, had metastasis, received immunotherapy reported poor physical functions. Breast cancer patients having multiple tumors, metastasis, and fever had lower scores regarding role limitations due to emotional problems. Breast cancer patients having multiple tumors and metastasis reported poor vitality. Breast cancer patients with fever reported low scores regarding emotional well-being. Social functioning was poorer in breast cancer patients with multiple tumors and metastasis ([Table 2](#t2-bctt-9-051){ref-type="table"}). We noted worse bodily pain in breast cancer patients with late-stage cancer (III or IV), multiple tumors, metastasis, and fever ([Figure 1](#f1-bctt-9-051){ref-type="fig"}). We discovered poor general health in patients with multiple tumors, metastasis, and fever. However, the general health of patients was better in patients who regularly exercised.

According to linear regression analyses ([Table 3](#t3-bctt-9-051){ref-type="table"}), breast cancer patients with a fever tended to have worse emotional well-being and social function (a decrease in SF-36 scores of 9.1 and 11.0, respectively) when compared with breast cancer patients with no fever. Metastasis was predictive of decreasing physical function, vitality, general health, and increasing bodily pain (with scores of 22.9, 15.0, 16.9, and 19.4, respectively). Employment was predictive of worsening role limitations due to emotional problems, vitality, and emotional well-being (a decrease in SF-36 scores of 20.4, 9.4, and 10.1, respectively). Breast cancer patients who received immunotherapy were predicted to have less vitality and increased pain by scores of 7.2 and 10.8, respectively. Multiple tumors were predicted to worsen role limitations due to emotional problems and social function by scores of 31.6 and 20.6, respectively. Newly diagnosed breast cancer patients with first-year-after-diagnosis tended to have a decrease in social function by a score of 14.2. However, regular exercise was predictive of better general health by an increased score of 8.2. Social function tended to decrease by 0.4 as age increased by one year.

Discussion
==========

The aim of this study was to assess the QoL of Saudi women with breast cancer and compare it with their sociodemographic and clinical factors. Despite the fact that QoL assessment has now become part of cancer clinical research trials and studies, there is very limited data existing on QoL in Saudi Arabia. We noted low SF-36 scores with minimum average values of 29.3 (role limitations due to physical health) and a maximum average value of 61.4 (emotional well-being). However, these scores were lower than those found in Saudi women with sickle cell disease, except for pain and emotional well-being where both populations reported similar scores.[@b40-bctt-9-051] The study supports evidence of findings in the existing literature, which indicates that breast cancer survivors report poor QoL. A study in Saudi Arabia showed breast cancer survivors reported a low overall global QoL,[@b29-bctt-9-051] whereas Chinese and U.S. breast cancer survivors reported poor QoL.[@b41-bctt-9-051] A study in Sweden reported poorer QoL in newly diagnosed breast cancer patients when compared with the normative population.[@b42-bctt-9-051] Our study suggested that employment was a negative predictor of role limitations due to emotional problems, vitality, and emotional well-being.

In this study, significant differences were observed in physical functions when measured by age groups and education levels. Elderly (age ≥60 years) women reported poorer physical function than women of ages \<60 years (mean difference=−17.9, *P*=0.002). Breast cancer patients with a university degree reported better physical function than those with a high school education or less (mean difference=17.7, *P*=0.001). These confirmed the findings from previous studies that QoL in breast cancer patients was negatively affected by patient age[@b8-bctt-9-051],[@b43-bctt-9-051] and positively affected by education levels.[@b44-bctt-9-051],[@b45-bctt-9-051]

We noted that breast cancer patients who reported having metastasis and multiple tumors have pain, very poor physical functions, role limitations due to emotional problems, little vitality, low social functioning, and poor general health. Metastasis[@b46-bctt-9-051],[@b47-bctt-9-051] and multiple tumors[@b48-bctt-9-051] have been linked with poor QoL in previous studies. According to our study, fever indicates considerable deterioration in the breast cancer patient's QoL. Fever tends to worsen several SF-36 domains: role limitations due to emotional problems, emotional well-being, pain, and general health. This could be due to the indirect effect of treatment on QoL, since research has indicated that fever may result from adverse treatment effects.[@b49-bctt-9-051]

Limitations
===========

We noted several limitations in conducting this research: findings must be interpreted with caution as the cross-sectional study assesses associations and may not allow causality. There is a potential for selection bias, in that patients who are attending our Oncology Outpatient Clinic may more often be likely to participate in the study, given the perceived severity of their cancer. The Generic SF-36 questionnaire was used to measure QoL and not as a breast cancer-specific measure. In our population, SF-36 appears to be a reliable assessment of QoL, and this research has clearly identified several factors that appear to affect QoL in breast cancer patients. This study is of interest to QoL researchers, cancer researchers, providers caring for cancer patients, and cancer patients. This study could be of value to the kingdom's health system in promoting the QoL of Saudi women with breast cancer by introducing educational programs or by endorsing/sponsoring public health policies.

Conclusion
==========

In Saudi breast cancer patients, regular exercise was a significant positive predictor of increased general health. In several SF-36 domains, Saudi breast cancer patients with multiple tumors, metastasis, or fever tend to experience significantly poor QoL. For such breast cancer patients, the effectiveness of interventional programs, such as regular exercise, should be assessed to maintain and improve QoL. Thus, it is important to provide routine assessment of QoL in breast cancer patients.
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###### 

Differences in quality of life by demographic and clinical characteristics (N=145)

  Characteristics                     Levels       Overall, N=145   Physical functioning, 54.5±28.8   Role limitations due to physical health, 29.3±38.3   Role limitations due to emotional problems, 33.6±42.1                               
  ----------------------------------- ------------ ---------------- --------------------------------- ---------------------------------------------------- ------------------------------------------------------- ------------- ------------- --------------------------------------------------
  Elderly                             No           113 (77.9)       58.4 (27.6)                       0.002[\*](#tfn1-bctt-9-051){ref-type="table-fn"}     27.4 (37.6)                                             0.270         31.9 (41.2)   0.363
  Yes                                 32 (22.1)    40.5 (28.7)                                        35.9 (40.6)                                                                                                  39.6 (45.9)                 
  University                          No           98 (67.6)        48.7 (26.8)                       0.001[\*](#tfn1-bctt-9-051){ref-type="table-fn"}     30.1 (38.0)                                             0.721         34.0 (41.7)   0.854
  Yes                                 47 (32.4)    66.4 (29.2)                                        27.7 (39.4)                                                                                                  32.6 (43.7)                 
  Employed                            No           108 (74.5)       51.1 (27.0)                       0.015                                                31.0 (38.6)                                             0.361         37.3 (43.6)   0.045
  Yes                                 37 (25.5)    64.3 (31.6)                                        24.3 (37.5)                                                                                                  22.5 (36.1)                 
  Married                             No           37 (25.5)        49.1 (28.9)                       0.187                                                31.1 (36.5)                                             0.746         31.5 (38.4)   0.736
  Yes                                 108 (74.5)   56.3 (28.6)                                        28.7 (39.1)                                                                                                  34.3 (43.6)                 
  Obese                               No           76 (62.8)        53.9 (28.3)                       0.741                                                34.2 (41.4)                                             0.194         34.2 (44.2)   0.869
  Yes                                 45 (37.2)    55.8 (31.2)                                        25.0 (35.0)                                                                                                  35.6 (41.7)                 
  Family history of cancer            No           84 (57.9)        54.0 (29.1)                       0.882                                                35.1 (40.2)                                             0.028         38.5 (44.7)   0.091
  Yes                                 61 (42.1)    55.1 (28.4)                                        21.3 (34.4)                                                                                                  26.8 (37.9)                 
  First-year-after-cancer diagnosis   No           69 (47.6)        52.4 (27.3)                       0.414                                                25.7 (35.1)                                             0.281         32.4 (40.4)   0.745
  Yes                                 76 (52.4)    56.3 (30.0)                                        32.6 (41.0)                                                                                                  34.6 (44.0)                 
  Cancer stage                        I/II         79 (61.2)        61.5 (27.6)                       0.005                                                31.3 (38.3)                                             0.489         40.1 (44.1)   0.016
  III/IV                              50 (38.8)    47.0 (28.2)                                        26.5 (38.9)                                                                                                  22.7 (35.9)                 
  Multiple tumors                     No           108 (74.5)       58.9 (27.9)                       0.001[\*](#tfn1-bctt-9-051){ref-type="table-fn"}     32.2 (39.7)                                             0.095         41.4 (44.4)   0.001[\*](#tfn1-bctt-9-051){ref-type="table-fn"}
  Yes                                 37 (25.5)    41.5 (27.5)                                        20.9 (33.1)                                                                                                  10.8 (23.6)                 
  Cancer surgery                      No           51 (35.2)        56.2 (30.9)                       0.596                                                33.8 (40.9)                                             0.298         31.4 (41.3)   0.647
  Yes                                 94 (64.8)    53.5 (27.6)                                        26.9 (36.9)                                                                                                  34.8 (42.9)                 
  Chemotherapy                        No           39 (26.9)        55.0 (28.4)                       0.889                                                34.6 (39.2)                                             0.314         35.9 (44.2)   0.688
  Yes                                 106 (73.1)   54.2 (29.0)                                        27.4 (38.0)                                                                                                  32.7 (41.7)                 
  Radiation therapy                   No           61 (42.1)        52.8 (30.6)                       0.555                                                30.7 (38.8)                                             0.704         27.3 (37.8)   0.120
  Yes                                 84 (57.9)    55.7 (27.5)                                        28.3 (38.2)                                                                                                  38.1 (44.9)                 
  Immunotherapy                       No           74 (51.0)        61.8 (28.0)                       0.001[\*](#tfn1-bctt-9-051){ref-type="table-fn"}     33.8 (41.7)                                             0.151         39.6 (44.7)   0.076
  Yes                                 71 (49.0)    46.8 (27.7)                                        24.6 (34.2)                                                                                                  27.2 (38.8)                 
  Antibodies                          No           102 (72.3)       57.3 (27.5)                       0.074                                                29.7 (38.0)                                             0.949         35.9 (43.4)   0.453
  Yes                                 39 (27.7)    47.6 (31.6)                                        30.1 (40.6)                                                                                                  29.9 (40.3)                 
  Metastasis                          No           101 (69.7)       60.3 (26.4)                       0.001[\*](#tfn1-bctt-9-051){ref-type="table-fn"}     31.4 (38.8)                                             0.314         41.6 (44.6)   0.001[\*](#tfn1-bctt-9-051){ref-type="table-fn"}
  Yes                                 44 (30.3)    40.9 (29.7)                                        24.4 (37.2)                                                                                                  15.2 (29.2)                 
  Fever                               No           91 (62.8)        56.1 (30.1)                       0.371                                                33.5 (39.8)                                             0.086         41.0 (44.7)   0.003[\*](#tfn1-bctt-9-051){ref-type="table-fn"}
  Yes                                 54 (37.2)    51.7 (26.3)                                        22.2 (34.9)                                                                                                  21.0 (34.4)                 
  Family support                      No           14 (9.7)         62.9 (32.0)                       0.251                                                21.4 (33.8)                                             0.420         31.0 (46.2)   0.809
  Yes                                 131 (90.3)   53.5 (28.4)                                        30.2 (38.8)                                                                                                  33.8 (42.0)                 
  Chronic disease other than cancer   No           93 (64.1)        59.3 (27.9)                       0.006                                                30.1 (40.0)                                             0.739         31.2 (41.6)   0.366
  Yes                                 52 (35.9)    45.8 (28.5)                                        27.9 (35.6)                                                                                                  37.8 (43.3)                 
  Regular exercise                    No           99 (68.3)        51.8 (29.5)                       0.106                                                29.0 (39.7)                                             0.902         32.3 (43.0)   0.606
  Yes                                 46 (31.7)    60.1 (26.6)                                        29.9 (35.6)                                                                                                  36.2 (40.9)                 

**Note:**

The variable is significant using the Bonferroni correction cutoff at α/n=0.05/19=0.003, where n is the number of tests.

**Abbreviation:** SD, standard deviation.

###### 

Differences in quality of life by demographic and clinical characteristics (N=145)

  Characteristics                     Vitality, 43.9±20.8   *P*-value     Emotional wellbeing, 61.4±20.0                     *P*-value     Social functioning, 58.4±28.2                      *P*-value     Pain, 49.0±26.6                                    *P*-value     General health, 50.7±19.2                          *P*-value     
  ----------------------------------- --------------------- ------------- -------------------------------------------------- ------------- -------------------------------------------------- ------------- -------------------------------------------------- ------------- -------------------------------------------------- ------------- --------------------------------------------------
  Elderly                             No                    44.2 (20.3)   0.740                                              59.8 (20.6)   0.062                                              59.0 (28.1)   0.633                                              48.5 (27.1)   0.632                                              51.3 (19.2)   0.486
  Yes                                 42.8 (22.7)                         67.3 (17.0)                                                      56.3 (28.9)                                                      51.0 (25.2)                                                      48.6 (19.3)                                                      
  University                          No                    43.4 (21.4)   0.660                                              63.0 (19.6)   0.162                                              61.1 (28.8)   0.092                                              47.6 (27.1)   0.349                                              50.9 (18.9)   0.837
  Yes                                 45.0 (19.6)                         58.0 (20.7)                                                      52.7 (26.4)                                                      52.0 (25.5)                                                      50.2 (19.9)                                                      
  Employed                            No                    44.9 (21.0)   0.319                                              63.7 (19.0)   0.020                                              61.1 (26.7)   0.045                                              49.6 (25.8)   0.651                                              50.7 (18.5)   0.996
  Yes                                 40.9 (20.3)                         54.8 (21.7)                                                      50.3 (31.4)                                                      47.3 (29.2)                                                      50.7 (21.4)                                                      
  Married                             No                    44.5 (19.2)   0.850                                              63.5 (13.6)   0.371                                              59.8 (26.0)   0.721                                              50.1 (24.6)   0.768                                              52.8 (18.9)   0.432
  Yes                                 43.7 (21.4)                         60.7 (21.8)                                                      57.9 (29.0)                                                      48.6 (27.4)                                                      50.0 (19.3)                                                      
  Obese                               No                    44.5 (19.8)   0.631                                              61.3 (18.9)   0.918                                              57.2 (28.7)   0.495                                              49.7 (28.7)   0.749                                              50.5 (17.8)   0.982
  Yes                                 42.7 (22.1)                         60.9 (20.0)                                                      60.8 (26.5)                                                      48.1 (23.1)                                                      50.4 (20.7)                                                      
  Family history of cancer            No                    46.0 (21.3)   0.151                                              64.0 (19.9)   0.073                                              63.1 (28.1)   0.017                                              52.8 (28.1)   0.039                                              51.6 (19.0)   0.501
  Yes                                 41.0 (19.9)                         57.9 (19.9)                                                      51.8 (27.3)                                                      43.8 (23.7)                                                      49.4 (19.5)                                                      
  First-year-after-cancer diagnosis   No                    43.4 (23.7)   0.791                                              63.7 (21.3)   0.200                                              62.7 (29.9)   0.079                                              49.7 (29.4)   0.766                                              52.9 (18.3)   0.188
  Yes                                 44.3 (17.9)                         59.4 (18.7)                                                      54.4 (26.2)                                                      48.4 (24.0)                                                      48.7 (19.9)                                                      
  Cancer stage                        I/II                  47.7 (18.8)   0.005                                              63.0 (19.7)   0.086                                              62.2 (24.1)   0.114                                              54.2 (24.7)   0.002[\*](#tfn3-bctt-9-051){ref-type="table-fn"}   53.7 (18.4)   0.008
  III/IV                              37.6 (21.3)                         56.8 (19.8)                                                      53.8 (32.1)                                                      39.9 (26.6)                                                      44.6 (18.7)                                                      
  Multiple tumors                     No                    47.2 (20.3)   0.001[\*](#tfn3-bctt-9-051){ref-type="table-fn"}   63.3 (20.1)   0.052                                              62.7 (26.7)   0.001[\*](#tfn3-bctt-9-051){ref-type="table-fn"}   54.3 (26.1)   0.001[\*](#tfn3-bctt-9-051){ref-type="table-fn"}   54.1 (18.3)   0.001[\*](#tfn3-bctt-9-051){ref-type="table-fn"}
  Yes                                 34.2 (19.3)                         55.9 (19.0)                                                      45.6 (28.9)                                                      33.6 (22.1)                                                      40.8 (18.6)                                                      
  Cancer surgery                      No                    43.0 (17.3)   0.716                                              63.2 (14.5)   0.367                                              55.1 (26.8)   0.314                                              49.5 (23.7)   0.870                                              46.6 (18.1)   0.057
  Yes                                 44.4 (22.6)                         60.4 (22.5)                                                      60.1 (28.9)                                                      48.8 (28.2)                                                      52.9 (19.5)                                                      
  Chemotherapy                        No                    45.0 (18.8)   0.700                                              62.1 (21.9)   0.815                                              59.3 (25.9)   0.810                                              51.5 (27.4)   0.502                                              50.1 (22.2)   0.832
  Yes                                 43.5 (21.6)                         61.2 (19.4)                                                      58.0 (29.1)                                                      48.1 (26.4)                                                      50.9 (18.1)                                                      
  Radiation therapy                   No                    43.3 (19.2)   0.762                                              62.8 (18.0)   0.472                                              56.8 (27.3)   0.563                                              49.7 (22.9)   0.782                                              50.7 (19.9)   0.980
  Yes                                 44.3 (22.0)                         60.4 (21.5)                                                      59.5 (29.0)                                                      48.5 (29.2)                                                      50.7 (18.8)                                                      
  Immunotherapy                       No                    48.5 (16.6)   0.006                                              63.0 (18.0)   0.339                                              57.9 (23.8)   0.856                                              55.2 (23.5)   0.004                                              52.0 (19.0)   0.418
  Yes                                 39.1 (23.6)                         59.8 (22.0)                                                      58.8 (32.3)                                                      42.5 (28.3)                                                      49.4 (19.5)                                                      
  Antibodies                          No                    44.9 (20.6)   0.521                                              60.4 (21.5)   0.359                                              59.1 (27.7)   0.388                                              51.1 (25.4)   0.216                                              51.1 (18.6)   0.850
  Yes                                 42.3 (22.1)                         63.9 (16.5)                                                      54.5 (29.3)                                                      44.9 (29.7)                                                      50.4 (21.3)                                                      
  Metastasis                          No                    48.7 (19.8)   0.001[\*](#tfn3-bctt-9-051){ref-type="table-fn"}   63.2 (20.8)   0.101                                              63.2 (26.4)   0.001[\*](#tfn3-bctt-9-051){ref-type="table-fn"}   55.6 (25.7)   0.001[\*](#tfn3-bctt-9-051){ref-type="table-fn"}   55.9 (18.0)   0.001[\*](#tfn3-bctt-9-051){ref-type="table-fn"}
  Yes                                 32.8 (19.0)                         57.3 (17.7)                                                      47.2 (29.4)                                                      34.0 (22.5)                                                      38.8 (16.6)                                                      
  Fever                               No                    47.7 (19.5)   0.004                                              66.5 (16.4)   0.001[\*](#tfn3-bctt-9-051){ref-type="table-fn"}   61.8 (25.5)   0.071                                              54.0 (25.1)   0.003[\*](#tfn3-bctt-9-051){ref-type="table-fn"}   54.5 (19.4)   0.002[\*](#tfn3-bctt-9-051){ref-type="table-fn"}
  Yes                                 37.5 (21.5)                         52.9 (22.8)                                                      52.5 (31.7)                                                      40.6 (27.2)                                                      44.3 (17.1)                                                      
  Family support                      No                    40.0 (23.6)   0.463                                              55.1 (21.8)   0.220                                              54.5 (27.6)   0.588                                              44.1 (23.7)   0.470                                              48.2 (16.1)   0.613
  Yes                                 44.3 (20.5)                         62.1 (19.8)                                                      58.8 (28.4)                                                      49.5 (26.9)                                                      51.0 (19.5)                                                      
  Chronic disease other than cancer   No                    44.6 (18.8)   0.602                                              60.6 (19.1)   0.542                                              58.3 (27.9)   0.987                                              52.4 (26.3)   0.039                                              52.5 (18.8)   0.135
  Yes                                 42.6 (24.1)                         62.8 (21.8)                                                      58.4 (29.0)                                                      42.9 (26.4)                                                      47.5 (19.7)                                                      
  Regular exercise                    No                    41.9 (21.3)   0.085                                              59.8 (21.0)   0.157                                              56.7 (29.3)   0.297                                              45.7 (27.2)   0.025                                              47.2 (19.3)   0.001[\*](#tfn3-bctt-9-051){ref-type="table-fn"}
  Yes                                 48.3 (19.3)                         64.9 (17.4)                                                      62.0 (25.7)                                                      56.3 (24.0)                                                      58.2 (16.8)                                                      

**Note:**

The variable is significant using the Bonferroni correction cutoff at α/n=0.05/19=0.003, where n is the number of tests.

**Abbreviation:** SD, standard deviation.

###### 

Multiple linear regression showing predictors of health-related quality of life in breast cancer patients

  Characteristics                     Physical functioning   Role limitations due to physical health   Role limitations due to emotional problems   Vitality   Emotional wellbeing   Social functioning   Pain    General health                                                           
  ----------------------------------- ---------------------- ----------------------------------------- -------------------------------------------- ---------- --------------------- -------------------- ------- ---------------- ------- ------- ------- ------- ------- ------- ------- -------
  Constant                            66.1                   0.001                                     −15.1                                        0.048      50.0                  0.001                55.7    0.001            70.3    0.001   103.6   0.001   60.6    0.001   58.1    0.001
  Age                                                                                                                                                                                                                                              −0.4    0.035                           
  University                          13.4                   0.013                                                                                                                                                                                 −16.5   0.002                           
  Employed                                                                                                                                                     −20.4                 0.018                −9.4    0.018            −10.1   0.009                                           
  Married                                                                                                                                                                                                                                                                                  
  Obese                                                                                                                                                                                                                                                                                    
  Family history of cancer                                                                             37.3                                         0.000                                                                          −8.5    0.017                                   −8.4    0.011
  First-year-after-cancer diagnosis                                                                                                                                                                                                                −14.2   0.004                           
  Cancer stage                                                                                                                                                                                                                                                                             
  Multiple tumors                                                                                                                                              −31.6                 0.001                                                         −20.6   0.001                           
  Cancer surgery                      −10.8                  0.047                                                                                                                                                                                                                         
  Chemotherapy                                                                                                                                                                                                                                                                             
  Radiation therapy                                                                                                                                                                                                                                                                        
  Immunotherapy                                                                                                                                                                                           −7.2    0.046                                            −10.8   0.020           
  Antibodies                                                                                                                                                                                                                                                                               
  Metastasis                          −22.9                  0.001                                                                                                                                        −15.0   0.001                                            −19.4   0.001   −16.9   0.001
  Fever                                                                                                                                                                                                                            −9.1    0.011   −11.0   0.026                           
  Family support                                                                                                                                                                                                                                                                           
  Chronic disease other than cancer                                                                                                                                                                                                                                                        
  Regular exercise                                                                                                                                                                                                                                                                 8.2     0.017
  **Model summary**                                                                                                                                                                                                                                                                        
  *F*-value                           10.1                   0.001                                     4.0                                          0.048      9.9                   0.001                8.9     0.001            7.0     0.001   7.0     0.001   13.1    0.001   12.1    0.001
  *R*^2^                              0.22                                                             0.04                                                    0.16                                       0.20                     0.17            0.26            0.20            0.26    
  *R*                                 0.47                                                             0.19                                                    0.40                                       0.45                     0.41            0.51            0.45            0.51    

**Notes:** B represents the partial regression coefficient. *F*-value represents the test value of overall significance of the linear regression model; *R*^2^ represents the proportion of variance explained; *R* represents multiple correlation coefficient.
